Argo Biopharma logo

Argo Biopharma

Committed to developing a new generation of siRNA drugs to provide better treatments for global patients.

8 employees · est. 2021 · Shanghai, China

VS
BBB Therapeutics logo

BBB Therapeutics

Combines existing drugs with it's proprietary for enhanced drug delivery across the blood-brain barrier

21 employees · est. 2003 · Leiden, The Netherlands

BBB Therapeutics is the older company (2021 vs 2003); BBB Therapeutics is the larger of the two.

Side-by-Side Comparison

Argo Biopharma BBB Therapeutics
Founded
2021 2003 older
Headquarters
Shanghai, China Leiden, The Netherlands
Employees
8 21 larger
Industry
Biotechnology Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Series A Unknown
Total Funding
$700.00M $21.00M
Funding Rounds
2 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Clinical Stage, Brain Disorders, Brain Cancer, Neuroinflammatory Diseases, Drug Development, G-Technology, Drug Delivery, Blood-brain Barrier, Clinical Trials, 2B3-101, 2B3-201, Phase IIa Trial, Phase I Clinical Study, Treatment
Website
argobiopharma.com bbbtherapeutics.com
Argo Biopharma logo

About Argo Biopharma

Argo Biopharma is a clinical stage biotech company that committed to developing a new generation of siRNA drugs to provide better treatments for global patients. In the past three years, Argo biopharma has built a rich and differentiated pipeline of siRNA drug candidates for a wide range of indicati...

BBB Therapeutics logo

About BBB Therapeutics

BBB Therapeutics, founded in 2003 and headquartered in The Netherlands, is a clinical stage biotechnology company that has carved a niche in developing treatments for critical brain disorders, including brain cancer and neuroinflammatory diseases. The company leverages its proprietary G-TechnologyĂ...

We will tell you when either one moves

BounceWatch watches Argo Biopharma and BBB Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Argo Biopharma and BBB Therapeutics — by email.

Frequently Asked Questions

Argo Biopharma — Committed to developing a new generation of siRNA drugs to provide better treatments for global patients.. BBB Therapeutics — Combines existing drugs with it's proprietary for enhanced drug delivery across the blood-brain barrier. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Argo Biopharma has raised $700.00M while BBB Therapeutics has raised $21.00M.
Argo Biopharma and BBB Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Argo Biopharma with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Argo Biopharma on 12 Sep 2024, and BBB Therapeutics on 23 Feb 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy